M28 Capital Management as of Sept. 30, 2024
Portfolio Holdings for M28 Capital Management
M28 Capital Management holds 11 positions in its portfolio as reported in the September 2024 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Wave Life Sciences SHS (WVE) | 55.5 | $51M | 6.2M | 8.20 | |
| Adagio Therapeutics (IVVD) | 10.4 | $9.4M | 9.2M | 1.02 | |
| Rocket Pharmaceuticals (RCKT) | 7.8 | $7.1M | 386k | 18.47 | |
| Fractyl Health (GUTS) | 5.2 | $4.7M | 1.9M | 2.53 | |
| Tg Therapeutics (TGTX) | 4.2 | $3.8M | 162k | 23.39 | |
| Springworks Therapeutics (SWTX) | 3.9 | $3.5M | 110k | 32.04 | |
| Silence Therapeutics Ads (SLN) | 3.7 | $3.4M | 185k | 18.18 | |
| Bridgebio Pharma (BBIO) | 3.4 | $3.1M | 121k | 25.46 | |
| Curis (CRIS) | 2.5 | $2.3M | 422k | 5.39 | |
| Proqr Thrapeutics N V Shs Euro (PRQR) | 2.0 | $1.9M | 1.0M | 1.82 | |
| Arrowhead Pharmaceuticals (ARWR) | 1.4 | $1.3M | 67k | 19.37 |
